IP Library Assignment 038950/0436
Patent Assignment
Reel/Frame 038950/0436

Security Interest

Recorded: 2016-06-10 Pages: 19
Assignors
ACORDA THERAPEUTICS, INC.
Executed: 2016-06-01
CIVITAS THERAPEUTICS, INC.
Executed: 2016-06-01
NEURONEX, INC.
Executed: 2016-06-01
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
277 PARK AVENUE, 22ND FLOOR, NEW YORK, NEW YORK, 10172
Covered Properties (88)
Methods of Increasing Myotube Formation or Survival, or Muscle Cell Mitogenesis, Differentiation or Survival Using Neuregulin Ggf Iii
Patent: 7,115,554 →
Application: 08/209,204 →
Methods for Treating Muscle Diseases and Disorders
Patent: 7,037,888 →
Application: 08/461,097 →
Methods for Treating Muscle Diseases and Disorders
Patent: 7,384,756 →
Application: 08/468,731 →
Method for Making Antibodies Which Specifically Bind to Glial Growth Factors
Patent: 5,876,973 →
Application: 08/469,660 →
Methods of Stimulating Mitogensis in Glial Cells Using Glial Mitogenic Factors
Patent: 6,232,286 →
Application: 08/470,339 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 7,135,456 →
Application: 08/471,833 →
Method for Prophylaxis or Treatment of a Nervous System, Pathophysiological Condition Involving a Glial Growth Factor Sensitive Cell by Administration of a Glial Growth Factor
Patent: 7,285,531 →
Application: 08/472,065 →
Method for Treating Congestive Heart Failure
Patent: 6,635,249 →
Application: 09/298,121 →
Nrg-2 Nucleic Acid Molecules, Polypeptides, and Diagnostic and Therapeutic Methods
Patent: 6,890,751 →
Application: 09/864,675 →
Publication: US 2002/0081286
Compositions and Methods for Promoting Neuronal Outgrowth
Patent: 8,183,350 →
Application: 10/513,573 →
Publication: US 2007/0274979
Compositions and methods including a recombinant human mab that promotes cns remyelination
Patent: 8,460,665 →
Application: 10/557,115 →
Publication: US 2007/0086999
Methods for Treating Congestive Heart Failure
Patent: 7,662,772 →
Application: 10/646,268 →
Publication: US 2007/0196379
Methods and Compositions for Administration of TRPV1 Agonists
Patent: 7,943,166 →
Application: 10/823,426 →
Publication: US 2005/0090557
Methods of Reducing Extravasation of Inflammatory Cells
Patent: 7,959,914 →
Application: 10/847,636 →
Publication: US 2004/0265297
Proteoglycan Degrading Mutants for the Treatment of Cns
Patent: 7,429,375 →
Application: 10/848,561 →
Publication: US 2006/0233782
Fusion Proteins for the Treatment of Cns
Patent: 8,906,363 →
Application: 10/848,564 →
Publication: US 2009/0028829
Methods for Protecting Dopaminergic Neurons from Stress and Promoting Proliferation and Differentiation of Oligodendrocyte Progenitors by Nrg-2
Patent: 8,114,838 →
Application: 11/085,812 →
Publication: US 2005/0261186
Oils of Capsaicinoids and Methods of Making and Using the Same
Patent: 7,771,760 →
Application: 11/394,495 →
Publication: US 2006/0233901
TRPV1 Agonist Compounds and Methods for Making and Using the Same
Patent: 7,632,519 →
Application: 11/411,328 →
Publication: US 2006/0240097
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 7,485,295 →
Application: 11/527,318 →
Publication: US 2007/0104703
Methods of Purifying Chondroitinase and Stable Formulations Thereof
Patent: 8,226,941 →
Application: 11/568,831 →
Publication: US 2008/0311642
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 7,722,864 →
Application: 11/870,350 →
Publication: US 2009/0060895
Proteoglycan Degrading Mutants for the Treatment of Cns
Patent: 7,968,089 →
Application: 12/167,573 →
Publication: US 2009/0041728
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 7,731,956 →
Application: 12/338,207 →
Publication: US 2009/0104176
Method for achieving desired glial growth factor 2 plasma levels
Patent: 8,410,050 →
Application: 12/380,760 →
Publication: US 2010/0029559
Methods for Detecting Cardiac Damage
Patent: 8,628,929 →
Application: 12/451,397 →
Publication: US 2011/0085976
Methods for Treating Congestive Heart Failure
Patent: 8,076,283 →
Application: 12/655,361 →
Publication: US 2010/0267618
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 8,236,302 →
Application: 12/757,006 →
Publication: US 2010/0239557
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 8,404,232 →
Application: 12/781,762 →
Publication: US 2011/0014158
Compositions and Kits for the Removal of Irritating Compounds from Bodily Surfaces
Patent: 8,263,059 →
Application: 12/830,997 →
Publication: US 2010/0269858
Use of a Neuregulin to Treat Peripheral Nerve Injury
Patent: 9,078,861 →
Application: 12/904,891 →
Publication: US 2011/0124561
Carbonate Prodrugs and Methods of Using the Same
Patent: 8,735,376 →
Application: 12/993,089 →
Publication: US 2011/0212927
Hepatoprotectant Acetaminophen Mutual Prodrugs
Application: 12/993,091 →
Publication: US 2011/0263545
Compositions and Methods for Treatment During Non-Acute Periods Following CNS Neurological Injury
Patent: 9,498,515 →
Application: 13/059,206 →
Publication: US 2011/0269682
Methods and Compositions for Administration of TRPV1 Agonists
Patent: 8,273,390 →
Application: 13/083,294 →
Publication: US 2011/0196043
Methods and Compositions for Administration of TRPV1 Agonists
Patent: 8,263,093 →
Application: 13/083,306 →
Publication: US 2011/0184069
Methods of Reducing Extravasation of Inflammatory Cells
Patent: 8,679,481 →
Application: 13/103,347 →
Publication: US 2011/0262413
Formulations for the Treatment of Pain
Patent: 8,889,736 →
Application: 13/232,905 →
Publication: US 2012/0238624
Methods for Treating Congestive Heart Failure
Patent: 8,394,761 →
Application: 13/292,193 →
Publication: US 2012/0065130
Compositions and Methods for Promoting Neuronal Outgrowth
Patent: 8,785,606 →
Application: 13/451,968 →
Publication: US 2012/0207732
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 8,852,583 →
Application: 13/543,749 →
Publication: US 2012/0308547
Methods and Compositions for Administration of TRPV1 Agonists
Patent: 8,734,770 →
Application: 13/585,692 →
Publication: US 2012/0309836
Compositions and Kits for the Removal of Irritating Compounds from Bodily Surfaces
Patent: 8,889,113 →
Application: 13/596,773 →
Publication: US 2012/0323258
Methods For Treating Congestive Heart Failure
Application: 13/656,179 →
Publication: US 2013/0040879
Capsules Containing High Doses of Levodopa for Pulmonary Use
Patent: 8,545,878 →
Application: 13/679,245 →
Devices and Methods for Puncturing a Capsule to Release a Powdered Medicament Therefrom
Application: 13/719,598 →
Publication: US 2014/0150787
Chimeric Protein
Application: 13/740,157 →
Publication: US 2013/0243765
Compositions and Methods including a Recombinant Human MAB that Promotes CNS Remyelination
Patent: 8,968,735 →
Application: 13/788,529 →
Publication: US 2013/0309240
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 9,102,930 →
Application: 13/849,420 →
Publication: US 2013/0210082
Method for Achieving Desired Glial Growth Factor 2 Plasma Levels
Patent: 9,272,015 →
Application: 13/853,386 →
Publication: US 2013/0345131
Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart Failure
Patent: 9,198,951 →
Application: 13/904,654 →
Publication: US 2013/0324466
Powder Inhaler Devices
Patent: 9,468,728 →
Application: 13/930,710 →
Publication: US 2014/0007874
Capsules Containing High Doses of Levodopa for Pulmonary Use
Patent: 8,685,442 →
Application: 13/945,160 →
Methods for Detecting Cardiac Damage
Patent: 9,329,171 →
Application: 14/153,695 →
Publication: US 2014/0378377
Intranasal Benzodiazepine Pharmaceutical Compositions
Application: 14/154,575 →
Publication: US 2014/0128381
Compositions and Methods for the Treatment of Cns Injuries
Application: 14/169,063 →
Publication: US 2014/0248253
Capsules Containing High Doses of Levodopa for Pulmonary Use
Patent: 8,945,612 →
Application: 14/174,179 →
Publication: US 2014/0220119
Proteoglycan Degrading Mutants for Treatment of Cns
Patent: 9,528,102 →
Application: 14/188,679 →
Publication: US 2014/0322192
Methods of Reducing Extravasation of Inflammatory Cells
Patent: 9,839,679 →
Application: 14/191,407 →
Publication: US 2014/0193387
Carbonate Prodrugs and Methods of Using the Same
Patent: 8,993,545 →
Application: 14/252,683 →
Publication: US 2014/0228326
Methods and Compositions for Administration of TRPV1 Agonists
Patent: 9,750,707 →
Application: 14/255,630 →
Publication: US 2015/0073056
Compositions and Methods for Promoting Neuronal Outgrowth
Patent: 9,468,671 →
Application: 14/317,106 →
Publication: US 2015/0023942
Acetaminophen Conjugates, Compositions and Methods of Use Thereof
Patent: 9,024,055 →
Application: 14/346,689 →
Publication: US 2014/0243407
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 9,402,886 →
Application: 14/480,486 →
Publication: US 2015/0190483
Formulations for the Treatment of Pain
Application: 14/517,603 →
Publication: US 2015/0250745
Fusion Proteins for the Treatment of Cns
Application: 14/535,113 →
Publication: US 2015/0299687
Compositions and Kits for the Removal of Irritating Compounds from Bodily Surfaces
Patent: 9,549,893 →
Application: 14/542,041 →
Publication: US 2015/0104498
Capsules Containing High Doses of Levodopa for Pulmonary Use
Patent: 9,393,210 →
Application: 14/575,454 →
Publication: US 2015/0320711
Methods for Protecting Dopaminergic Neurons from Stress and Promoting Proliferation and Differentiation of Oligodendrocyte Progenitors by Nrg-2
Application: 14/576,706 →
Publication: US 2015/0274795
Compositions and Methods Including a Recombinant Human Mab That Promotes Cns Remyelination
Patent: 9,751,943 →
Application: 14/603,553 →
Publication: US 2015/0299316
Carbonate Prodrugs and Methods of Using the Same
Patent: 9,289,501 →
Application: 14/629,324 →
Publication: US 2016/0024126
Use of a Neuregulin to Treat Peripheral Nerve Injury
Application: 14/689,923 →
Publication: US 2015/0216936
Methods for Reducing Inter-Patient Variability of Levodopa Plasma Concentrations
Patent: 9,295,661 →
Application: 14/691,788 →
Publication: US 2016/0015663
Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient
Application: 14/691,793 →
Publication: US 2015/0328175
Dosator Apparatus for Filling a Capsule with Dry Powder
Patent: 9,642,812 →
Application: 14/707,053 →
Publication: US 2015/0342890
Ultra Low Density Pulmonary Powders
Patent: 9,539,211 →
Application: 14/707,071 →
Publication: US 2015/0342885
Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart Failure
Application: 14/772,205 →
Publication: US 2016/0129084
Compositions and Methods of Using Chondroitinase Abci Mutants
Patent: 9,410,141 →
Application: 14/790,075 →
Publication: US 2015/0322422
Methods for Treating Congestive Heart Failure
Application: 14/844,475 →
Publication: US 2016/0113998
Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart Failure
Patent: 9,956,266 →
Application: 14/928,124 →
Publication: US 2016/0113999
Rapamycin Powders for Pulmonary Delivery
Patent: 9,387,169 →
Application: 14/934,491 →
Publication: US 2016/0128936
Use of Neuregulin to Treat Peripheral Nerve Injury
Application: 14/978,287 →
Publication: US 2016/0346353
Carbonate Prodrugs and Methods of Using the Same
Patent: 9,683,000 →
Application: 15/017,329 →
Publication: US 2017/0008916
Methods for Detecting Cardiac Damage
Patent: 9,757,429 →
Application: 15/053,284 →
Publication: US 2016/0263192
Water-Soluble Acetaminophen Analogs
Patent: 9,981,998 →
Application: 15/077,802 →
Publication: US 2016/0264605
Indicator for an Inhaler
Patent: 752,204 →
Application: 29/484,448 →
Indicator for an Inhaler
Patent: 755,367 →
Application: 29/484,449 →
Inhaler Grip
Patent: 752,734 →
Application: 29/484,451 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 6, 2004
From: CENES PHARAMACEUTICALS, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 016045/0306 →
Assignment of Assignor's Interest Dec 6, 2004
From: CENES PHARAMACEUTICALS, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 016075/0942 →
Assignment of Assignor's Interest May 10, 2005
From: GRUSKIN, ELLIOTT A; TSENG, JACK L; CAGGIANO, ANTHONY O
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 015990/0165 →
Security Interest May 31, 2005
From: CENES PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 016075/0555 →
Assignment of Assignor's Interest Mar 7, 2006
From: GRUSKIN, ELLIOTT A.; IACI, JENNIFER F.; VECCHIONE, ANDREA M.; KASPERBAUER, SARAH
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 017267/0539 →
Assignment of Assignor's Interest Jun 20, 2006
From: JAMIESON, GENE CURTIS; MUHAMMAD, NAWEED; BLEY, KEITH R.
To: NEUROGESX, INC.
Reel/Frame 017827/0291 →
Assignment of Assignor's Interest Jun 20, 2006
From: JAMIESON, GENE C.; MUHAMMAD, NAWEED; BLEY, KEITH R.
To: NEUROGESX, INC.
Reel/Frame 017827/0386 →
Assignment of Assignor's Interest Dec 18, 2006
From: WARRINGTON, ARTHUR E.; BIEBER, ALLAN J.; RODRIGUEZ, MOSES
To: MAYO FOUNDATION FOR MEDICAL EDUCATIONS AND RESEARCH
Reel/Frame 018713/0579 →
Assignment of Assignor's Interest Dec 18, 2006
From: GRUSKIN, ELLIOT A.; CHOJNICKI, ERIC
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 018684/0480 →
Assignment of Assignor's Interest Jan 17, 2007
From: CAGGIANO, ANTHONY O.; IACI, JENNIFER; VECCHIONE, ANDREA; MARKENSOHN, ELIZABETH
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 018766/0887 →
Assignment of Assignor's Interest Jun 2, 2009
From: KELLY, RALPH; SAWYER, DOUGLAS B.
To: BRIGHAM AND WOMEN'S HOSPITAL, INC., THE
Reel/Frame 022782/0356 →
Assignment of Assignor's Interest Jun 2, 2009
From: CENES PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 022782/0271 →
Assignment of Assignor's Interest Jun 2, 2009
From: MARCHIONNI, MARK
To: CENES PHARMACEUTICALS, INC.
Reel/Frame 022782/0353 →
Assignment of Assignor's Interest Jun 2, 2009
From: LORELL, BEVERLY
To: BETH ISRAEL DEACONESS MEDICAL CENTER
Reel/Frame 022782/0361 →
Security Agreement Nov 13, 2012
From: NEUROGESX, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 029291/0807 →
Assignment and Release of Security Interest Jul 10, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: NEUROGESX, INC.
Reel/Frame 030777/0782 →
Assignment of Assignor's Interest Dec 12, 2013
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 031775/0168 →
Confirmatory License Sep 23, 2015
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036670/0170 →
Release of Security Interest May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
Assignment of Assignor's Interest Jan 31, 2018
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 045130/0001 →
Assignment of Assignor's Interest Mar 2, 2018
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 045515/0320 →
Assignment of Assignor's Interest May 22, 2019
From: ACORDA THERAPEUTICS, INC.
To: GRÜNENTHAL GMBH
Reel/Frame 049260/0707 →
Assignment of Assignor's Interest Aug 15, 2019
From: GRÜNENTHAL GMBH
To: GRT US HOLDING, INC.
Reel/Frame 050065/0195 →
Confirmatory License Apr 1, 2023
From: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 063198/0323 →